---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-149802"
form_type: "8-K"
ticker: "GLUE"
cik: "0001826457"
company_name: "Monte Rosa Therapeutics, Inc."
filed_at: "2024-05-30T23:59:59+00:00"
generated_at: "2026-06-01T07:27:54.077860+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Monte Rosa Therapeutics promotes three executives to CSO, CBO/CLO, and COO

## Summary
- Sharon Townson, Ph.D., promoted to Chief Scientific Officer; previously CTO.
- Phil Nickson, Ph.D., J.D., promoted to Chief Business and Legal Officer; previously General Counsel.
- Jennifer Champoux promoted to Chief Operating Officer; previously Chief People and Operations Officer.
- All promotions effective immediately as of May 30, 2024.
- No departures announced; internal promotions reflect pipeline and platform advancement.

## SEC filing metadata
- accession: 0001193125-24-149802
- form_type: 8-K
- ticker: GLUE
- cik: 0001826457
- company_name: Monte Rosa Therapeutics, Inc.
- filed_at: 2024-05-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826457/000119312524149802/0001193125-24-149802-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826457/000119312524149802/d836893d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-149802
- JSON: https://secwatch.observer/filing/0001193125-24-149802.json
- Plain text: https://secwatch.observer/filing/0001193125-24-149802.txt

## Key facts
- Executive change
  Jennifer Champoux changed role as Chief Operating Officer at Monte Rosa Therapeutics, Inc..
  - Action: promoted
  - Role: Chief Operating Officer
  source text: On May 28, 2024, the Compensation, Nomination and Corporate Governance Committee of Board of Directors of Monte Rosa Therapeutics, Inc. (the “Company”) promoted Jennifer Champoux, the Company’s Chief People and Operations Officer, to serve as the Company’s Chief Operating Officer, effective as of May 28, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826457/000119312524149802/0001193125-24-149802-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.